Scholarly Index
Kimberly Goodspeed
Ultragenyx Pharmaceutical (United States); 1,194 total citations; 49 total publications; best world rank #164
Ultragenyx Pharmaceutical (United States)
1,194Total citations
49Total publications
12H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Williams Syndrome Research | Lifetime | 789 | US 314 | 53.12 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 210 | US 81 | 93.52 |
| Genomics and Rare Diseases | 2021-2025 | 697 | US 283 | 87.46 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 740 | US 250 | 76.17 |
| Williams Syndrome Research | 2021-2025 | 164 | US 53 | 35.15 |